FDA official reports or press releases

Study Finds mRNA COVID-19 Vaccine Linked to 60 Times Higher Heart Disease Risk; CDC Recommends 3 Doses for Infants 6 Months and Older

Oct 30, 2024, 11:12 AM

A recent peer-reviewed study indicates that individuals who received one dose of an mRNA COVID-19 vaccine have a higher risk of acute heart disease compared to those who received a non-mRNA vaccine. This finding raises concerns about the safety of mRNA vaccines, particularly in young males. Additionally, the FDA has been criticized for allegedly overestimating the benefit-risk ratio of the mRNA vaccine for males aged 18-25 by more than 60 times, based on new data regarding Omicron and myocarditis. The CDC's new guidelines recommend that infants aged 6 months and older receive three COVID-19 vaccinations, despite claims that there is insufficient scientific evidence demonstrating a reduction in hospitalizations or deaths. Critics argue that this recommendation may contribute to growing public distrust in health authorities, as the hospitalization and death rates from COVID-19 among infants and children are low. Furthermore, some experts suggest that natural immunity may be effective and that vaccines do not necessarily prevent the spread of the virus.